Frequently Asked Questions
Discover more about Trovagene’s Trovera tests through answers to common questions below.
Genes are functional stretches of DNA inside each of our cells. They instruct the cells on how to make the proteins our bodies need to function. Changes in these genes are called mutations, which play an important role in the development, growth, and spread of cancer. Certain mutations can cause cells to grow out of control, which can lead to cancer. To learn more about mutations, please visit this website: www.yourgenome.org/facts/what-is-a-mutation.
Trovagene uses the term Precision Cancer Monitoring® (PCM) to describe routine testing of cancer mutations with extremely high sensitivity in a noninvasive fashion. Thus, PCM enables more frequent insights into a tumor’s changes versus biopsies or scans.
As tumor cells grow and spread, they release their DNA into the blood. This DNA is called circulating tumor DNA (ctDNA) and can be found in urine and blood.
Cancer treatments known as “targeted therapies” are designed to target and stop the actions of specific mutations that may cause the cancer to grow and spread. It is important to know if you have a tumor with one of these mutations so you and your healthcare provider can make the best treatment decisions possible.
Patients will need to fill out an application that certifies that they are a United States citizen or legal resident, or a person with a valid visa in the United States and proof of income. Patients will also be asked to provide a W2, paystub, tax return, social security notice, and/or disability paperwork.
Up to 4x the federal poverty guidelines based on the Affordable Care Act.
Patients can provide monthly expenses, which supplement their income to be able to potentially increase their chances of qualifying for the program.